These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38010648)

  • 1. Consideration and Disclosure of Group Risks in Genomics and Other Data-Centric Research: Does the Common Rule Need Revision?
    Chapman CR; Quinn GP; Natri HM; Berrios C; Dwyer P; Owens K; Heraty S; Caplan AL
    Am J Bioeth; 2023 Nov; ():1-14. PubMed ID: 38010648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.
    Ernst AA; Fish S
    Acad Emerg Med; 2005 Nov; 12(11):1050-5. PubMed ID: 16264073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Big Health Data Research and Group Harm: The Scope of IRB Review.
    Doerr M; Meeder S
    Ethics Hum Res; 2022 Jul; 44(4):34-38. PubMed ID: 35802789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of Common Rule Changes to the Informed Consent Form: A Research Staff and Institutional Review Board Collaboration.
    Gartel G; Scuderi H; Servay C
    Ochsner J; 2020; 20(1):76-80. PubMed ID: 32284686
    [No Abstract]   [Full Text] [Related]  

  • 6. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research consent by adolescent minors and institutional review boards.
    Mammel KA; Kaplan DW
    J Adolesc Health; 1995 Nov; 17(5):323-30. PubMed ID: 8924437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A qualitative study of institutional review board members' experience reviewing research proposals using emergency exception from informed consent.
    McClure KB; Delorio NM; Schmidt TA; Chiodo G; Gorman P
    J Med Ethics; 2007 May; 33(5):289-93. PubMed ID: 17470507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability among institutional review boards' decisions within the context of a multicenter trial.
    Silverman H; Hull SC; Sugarman J
    Crit Care Med; 2001 Feb; 29(2):235-41. PubMed ID: 11246299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informed consent for research on stored blood and tissue samples: a survey of institutional review board practices.
    White MT; Gamm J
    Account Res; 2002; 9(1):1-16. PubMed ID: 12705242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation of community consultation and public disclosure for a pediatric multi-centered "Exception from Informed Consent" trial.
    Holsti M; Zemek R; Baren J; Stanley RM; Mahajan P; Vance C; Brown KM; Gonzalez V; King D; Jacobsen K; Shreve K; van de Bruinhorst K; Jones AM; Chamberlain JM
    Clin Trials; 2015 Feb; 12(1):67-76. PubMed ID: 25369796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual genetic and genomic research results and the tradition of informed consent: exploring US review board guidance.
    Simon C; Shinkunas LA; Brandt D; Williams JK
    J Med Ethics; 2012 Jul; 38(7):417-22. PubMed ID: 22361295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exception From Informed Consent: How IRB Reviewers Assess Community Consultation and Public Disclosure.
    Chisolm-Straker M; Nassisi D; Daya MR; Cook JNB; Wilets IF; Clesca C; Richardson LD
    AJOB Empir Bioeth; 2021; 12(1):24-32. PubMed ID: 32990501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Important Considerations for the Institutional Review Board When Granting Health Insurance Portability and Accountability Act Authorization Waivers.
    Williams K; Colomb P
    Ochsner J; 2020; 20(1):95-97. PubMed ID: 32284689
    [No Abstract]   [Full Text] [Related]  

  • 15. An Approach to Reviewing Local Context for Exception from Informed Consent Trials Using a Single IRB.
    Johnson AR; Rigtrup LM; VanBuren J; Rothwell E; Dean JM
    Ethics Hum Res; 2021 Nov; 43(6):42-48. PubMed ID: 34751515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U.S. Federal Regulations for emergency research: a practical guide and commentary.
    McRae A; Weijer C
    Acad Emerg Med; 2008 Jan; 15(1):88-97. PubMed ID: 18211320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of human participants in health research - a comparison of some US Federal Regulations and South African Research Ethics guidelines.
    Cleaton-Jones P; Wassenaar D
    S Afr Med J; 2010 Nov; 100(11):712-6. PubMed ID: 21081019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conducting research using the emergency exception from informed consent: the Public Access Defibrillation (PAD) Trial experience.
    Mosesso VN; Brown LH; Greene HL; Schmidt TA; Aufderheide TP; Sayre MR; Stephens SW; Travers A; Craven RA; Weisfeldt ML;
    Resuscitation; 2004 Apr; 61(1):29-36. PubMed ID: 15081178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conflicting interests, social justice and proxy consent to research.
    Pullman D
    J Med Philos; 2002 Oct; 27(5):523-45. PubMed ID: 12461709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conducting industrial and organizational psychological research: institutional review of research in work organizations.
    Ilgen DR; Bell BS
    Ethics Behav; 2001; 11(4):395-412. PubMed ID: 11838504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.